Spartan Bioscience Receives Health Canada Authorization for Made-In-Canada Rapid COVID-19 Test

January 23rd, 2021

Spartan Bioscience announced today it has received approval from Health Canada and is now authorized to sell the Spartan COVID-19 System, a rapid, on-site molecular diagnostic test for the qualitative detection of SARS-CoV-2, the virus causing COVID-19. S...

Read more

Spartan Bioscience Submits Rapid, Portable COVID-19 Test to Health Canada For Approval

December 14th, 2020

Ottawa, Ontario - Spartan Bioscience today announced it has officially re-submitted its rapid, accurate, and portable COVID-19 test for Health Canada review. This is the final step in Canada’s regulatory process. Once approved, Spartan will immediately be...

Read more

Spartan Bioscience Appoints Roger Eacock as Chief Executive Officer, Broadens Executive Team and Welcomes New Board Members

November 10th, 2020

Spartan Bioscience is pleased to announce a strengthened executive leadership team and new members of the Board of Directors. These significant additions position Spartan for the next phase of the company’s growth and include a new Chief Executive Officer...

Read more

Spartan Bioscience Receives Investigational Testing Authorization (ITA) from Health Canada

October 29th, 2020

Spartan Bioscience is pleased to announce we have received Investigational Testing Authorization (ITA) from Health Canada for our COVID-19 testing system. ITA allows Spartan to begin its clinical validation studies on symptomatic patients in Canada. These...

Read more

Spartan Submits COVID-19 Testing System to Health Canada for Investigational Testing Authorization (ITA)

September 21st, 2020

Spartan Bioscience has commenced the regulatory process of its revised COVID-19 point-of-care test and submitted an Investigational Testing Authorization (ITA) application to Health Canada for its review and approval. Upon approval, Spartan will commence...

Read more